MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
Income Quality Over TimeContracting
Percentile Rank20
3Y CAGR-8.5%
5Y CAGR-24.5%
Studio
Year-over-Year Change

Quality of reported income

3Y CAGR
-8.5%/yr
Annual compound
5Y CAGR
-24.5%/yr
Recent acceleration
Percentile
P20
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
20250.86-11.0%
20240.96-0.9%
20230.97-13.2%
20221.12+70.6%
20210.66-81.2%
20203.49-